Journal article

Technology in Parkinson's disease: Challenges and opportunities

Alberto J Espay, Paolo Bonato, Fatta B Nahab, Walter Maetzler, John M Dean, Jochen Klucken, Bjoern M Eskofier, Aristide Merola, Fay Horak, Anthony E Lang, Ralf Reilmann, Joe Giuffrida, Alice Nieuwboer, Malcolm Horne, Max A Little, Irene Litvan, Tanya Simuni, E Ray Dorsey, Michelle A Burack, Ken Kubota Show all

Movement Disorders | WILEY-BLACKWELL | Published : 2016


Awarded by Parkinson's UK

Funding Acknowledgements

The MDS Technology Task Force assembled a group of experts from the device and biopharmaceutical industry, clinical researchers, and engineers. The authors have taken every effort to minimize the influence of their home institutions and industries on the summarized outcome of the deliberations. A.J.E. has received grant support from Great Lakes Neurotechnologies. He serves as chair of the MDS Technology Task Force. P.B. is supported by the Michael J Fox Foundation, the National Institutes of Health, the National Science Foundation, and the Office of Naval Research. F.N. has received an educational grant from Medtronic Inc. W.M. has received grants from the European Union for FAIR-PARK-II, Moving beyond and SENSE-PARK. J.M.D. is supported by the Davis Phinney Foundation to direct their Healthcare Strategy and Technology division. J.K. has received grant support Astrum IT and LicherMT and is chair of the task force "sensor-based movement analysis" of the German Parkinson Society. B.M.E. has received grant support from Bosch Sensortec and Astrum IT and is co-chair of the task force "sensor-based movement analysis" of the German Parkinson Society. F.H. has research grants from Medtronic and has an equity/interest in APDM, a technology company. A.E.L. has served as an advisor for and received honoraria from Medtronic. R.R. is founding director and owner of the George-Huntington-Institute, a private research institute and QuantiMedis, a clinical research organization providing Q-Motor (quantitative motor) services in clinical trials and research. J.G. is a full-time employee of Great Lakes Neurotechnologies. M.H. has a financial interest in Global Kinetics Corporation, a company that manufactures and supplies the Parkinson's KinetiGraph (PKG), a wearable technology. M.A.L. has nothing to disclose. T.S. has received funding support for educational programming from GE Medical and Medtronic. E.R.D. has filed for a patent related to telemedicine and neurology and has received research funding from Great Lakes Neurotechnologies and Prana Biotechnology. K.K. directs data science and the partnership with Intel on wearable technologies and analytics enacted through the Michael J Fox Foundation for Parkinson's Research full time. G.M. is the founder and chief executive officer of Apptomics LLC. L.K. is a full-time employee of Medtronic and serves as Board Observer at Functional Neuromodulation, Ltd. J.M.H. submitted a patent application on the use of body-fixed sensors in Parkinson disease. The intellectual property rights for this patent application are held by the Tel Aviv Sourasky Medical Center. B.R.B. received research support from the Netherlands Organization for Scientific Research, the Michael J Fox Foundation, the Prinses Beatrix Foundation, the Stichting Parkinson Fonds, the National Parkinson Foundation, the Hersenstichting Nederland and the Parkinson Vereniging. S.P. is a full-time employee of TEVA Pharmaceuticals. He serves as co-chair of the MDS Technology Task Force. All other authors have no financial disclosure to report related to research covered in this article.